肾上腺皮质癌
Adrenocortical Carcinoma.
作者信息
Berruti Alfredo, Tiberio Guido Alberto Massimo, Sigala Sandra
机构信息
Medical Oncology Unit, Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia, ASST Spedali Civili of Brescia, 25123 Brescia, Italy.
Surgical Unit, Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia, ASST Spedali Civili of Brescia, 25123 Brescia, Italy.
出版信息
Cancers (Basel). 2021 Mar 3;13(5):1077. doi: 10.3390/cancers13051077.
Abstract
Adrenocortical carcinoma (ACC) is an extremely rare disease, the incidence of which is 0 [...].
摘要
肾上腺皮质癌（ACC）是一种极其罕见的疾病，其发病率为0 [...]。
相似文献
1
Adrenocortical Carcinoma.肾上腺皮质癌
Cancers (Basel). 2021 Mar 3;13(5):1077. doi: 10.3390/cancers13051077.
2
An Interesting Case of Hepatic Adrenocortical Carcinoma.肝肾上腺皮质癌的一个有趣病例
Acta Med Indones. 2018 Jul;50(3):257-259.
3
ADRENOCORTICAL CARCINOMA: IN THE SEARCH FOR A PRE-OPERATIVE BIOMARKER.肾上腺皮质癌：寻找术前生物标志物
Acta Endocrinol (Buchar). 2017 Jul-Sep;13(3):340-341. doi: 10.4183/aeb.2017.340.
4
Management of Adrenocortical Carcinoma.肾上腺皮质癌的治疗。
Curr Oncol Rep. 2019 Feb 23;21(3):20. doi: 10.1007/s11912-019-0773-7.
5
Past, Present and Future of Epigenetics in Adrenocortical Carcinoma.肾上腺皮质癌表观遗传学的过去、现在与未来
Cancers (Basel). 2020 May 13;12(5):1218. doi: 10.3390/cancers12051218.
6
Surgical management of adrenocortical carcinoma.肾上腺皮质癌的外科治疗
Endocrinol Metab Clin North Am. 2015 Jun;44(2):435-52. doi: 10.1016/j.ecl.2015.02.008. Epub 2015 Mar 17.
7
Pitfalls in the diagnosis of adrenocortical tumors: a lesson from 300 consultation cases.肾上腺皮质肿瘤诊断中的陷阱：来自300例会诊病例的经验教训
Hum Pathol. 2015 Dec;46(12):1799-807. doi: 10.1016/j.humpath.2015.08.012. Epub 2015 Sep 11.
8
microRNA-431 as a Chemosensitizer and Potentiator of Drug Activity in Adrenocortical Carcinoma.microRNA-431 作为促肾上腺皮质癌化疗增敏剂和药物活性增强剂。
Oncologist. 2019 Jun;24(6):e241-e250. doi: 10.1634/theoncologist.2018-0849. Epub 2019 Mar 27.
9
Serum inhibin pro-αC is a tumor marker for adrenocortical carcinomas.血清抑制素 pro-αC 是肾上腺皮质癌的肿瘤标志物。
Eur J Endocrinol. 2012 Feb;166(2):281-9. doi: 10.1530/EJE-11-0693. Epub 2011 Nov 29.
10
Analysis of IGF and IGFBP as prognostic serum biomarkers for adrenocortical carcinoma.胰岛素样生长因子（IGF）和胰岛素样生长因子结合蛋白（IGFBP）作为肾上腺皮质癌血清预后生物标志物的分析
Ann Surg Oncol. 2014 Oct;21(11):3541-7. doi: 10.1245/s10434-014-3768-5. Epub 2014 May 16.
引用本文的文献
1
Emerging role of IGF1R and IR expression and localisation in adrenocortical carcinomas.胰岛素样生长因子1受体（IGF1R）及胰岛素受体（IR）的表达与定位在肾上腺皮质癌中的新作用
Cell Commun Signal. 2025 Mar 4;23(1):119. doi: 10.1186/s12964-025-02115-0.
2
Role of filamin A in the pathogenesis of neuroendocrine tumors and adrenal cancer.细丝蛋白A在神经内分泌肿瘤和肾上腺癌发病机制中的作用。
Endocr Oncol. 2022 Oct 28;2(1):R143-R152. doi: 10.1530/EO-22-0055. eCollection 2022 Jan.
3
Construction and validation of a prognostic model for predicting overall survival of primary adrenal malignant tumor patients: A population-based study with 1,080 patients.预测原发性肾上腺恶性肿瘤患者总生存期的预后模型的构建与验证：一项基于1080例患者的人群研究。
Front Surg. 2022 Oct 24;9:1025213. doi: 10.3389/fsurg.2022.1025213. eCollection 2022.
本文引用的文献
1
Prognostic and Monitoring Value of Circulating Tumor Cells in Adrenocortical Carcinoma: A Preliminary Monocentric Study.循环肿瘤细胞在肾上腺皮质癌中的预后及监测价值：一项初步的单中心研究
Cancers (Basel). 2020 Oct 29;12(11):3176. doi: 10.3390/cancers12113176.
2
Development and Internal Validation of a Multivariable Prediction Model for Adrenocortical-Carcinoma-Specific Mortality.肾上腺皮质癌特异性死亡率多变量预测模型的开发与内部验证
Cancers (Basel). 2020 Sep 22;12(9):2720. doi: 10.3390/cancers12092720.
3
Adrenocortical carcinomas and malignant phaeochromocytomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up.肾上腺皮质癌和恶性嗜铬细胞瘤：ESMO-EURACAN诊断、治疗及随访临床实践指南
Ann Oncol. 2020 Nov;31(11):1476-1490. doi: 10.1016/j.annonc.2020.08.2099. Epub 2020 Aug 27.
4
Adrenocortical Carcinoma and CT Assessment of Therapy Response: The Value of Combining Multiple Criteria.肾上腺皮质癌与CT对治疗反应的评估：综合多种标准的价值
Cancers (Basel). 2020 May 28;12(6):1395. doi: 10.3390/cancers12061395.
5
Past, Present and Future of Epigenetics in Adrenocortical Carcinoma.肾上腺皮质癌表观遗传学的过去、现在与未来
Cancers (Basel). 2020 May 13;12(5):1218. doi: 10.3390/cancers12051218.
6
Hyperthermic Intraperitoneal Chemotherapy for Primary or Recurrent Adrenocortical Carcinoma. A Single Center Study.原发性或复发性肾上腺皮质癌的热灌注腹腔内化疗。单中心研究。
Cancers (Basel). 2020 Apr 14;12(4):969. doi: 10.3390/cancers12040969.
7
Efficacy of the EDP-M Scheme Plus Adjunctive Surgery in the Management of Patients with Advanced Adrenocortical Carcinoma: The Brescia Experience.EDP-M方案联合辅助手术治疗晚期肾上腺皮质癌患者的疗效：布雷西亚经验
Cancers (Basel). 2020 Apr 10;12(4):941. doi: 10.3390/cancers12040941.
8
Cytotoxic Effect of Trabectedin In Human Adrenocortical Carcinoma Cell Lines and Primary Cells.曲贝替定对人肾上腺皮质癌细胞系和原代细胞的细胞毒性作用。
Cancers (Basel). 2020 Apr 9;12(4):928. doi: 10.3390/cancers12040928.
9
Mitotane Concentrations Influence Outcome in Patients with Advanced Adrenocortical Carcinoma.米托坦浓度影响晚期肾上腺皮质癌患者的预后。
Cancers (Basel). 2020 Mar 20;12(3):740. doi: 10.3390/cancers12030740.
10
Early Postoperative Circulating miR-483-5p Is a Prognosis Marker for Adrenocortical Cancer.术后早期循环miR-483-5p是肾上腺皮质癌的预后标志物。
Cancers (Basel). 2020 Mar 19;12(3):724. doi: 10.3390/cancers12030724.
Zotero 插件